Ultragenyx Pharmaceutical... (RARE)

NASDAQ: RARE · Real-Time Price · USD

38.96

-0.02 (-0.05%)

At close: May 01, 2025, 3:59 PM

38.97

0.03%

After-hours: May 01, 2025, 04:01 PM EDT

Ultragenyx Pharmaceutical Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	560.23M	434.25M	363.33M	351.41M	271.03M	103.71M	51.49M	2.61M	133K
Cost of Revenue	76.73M	45.21M	28.32M	16.01M	6.13M	9.01M	1.15M	1K	183.2M
Gross Profit	483.5M	389.04M	335.01M	335.4M	264.9M	94.71M	50.35M	2.61M	-183.07M
Operating Income	-535.97M	-569.21M	-648.92M	-381.74M	-330.12M	-424.17M	-371.37M	-328.94M	-248.01M
Interest Income	36.51M	26.69M	11.07M	1.93M	7.04M	13.24M	9.54M	4.07M	3.79M
Pretax Income	-567.59M	-608.46M	-701.73M	-452.98M	-185.36M	-399.44M	-197.1M	-318.34M	-245.84M
Net Income	-569.18M	-606.64M	-707.42M	-454.02M	-186.57M	-402.73M	-197.61M	-302.14M	-245.87M
Selling & General & Admin	321.61M	309.8M	278.14M	219.98M	182.93M	161.52M	127.72M	99.91M	64.94M
Research & Development	697.87M	648.45M	705.79M	497.15M	412.08M	357.36M	294M	231.64M	183.2M
Other Expenses	n/a	n/a	9.51M	241K	7.64M	12.45M	3.95M	10.6M	2.17M
Operating Expenses	1.02B	958.25M	983.93M	717.13M	595.02M	518.88M	421.72M	331.55M	248.14M
Interest Expense	63.04M	66M	43.02M	29.42M	33.29M	1.14M	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	1.1B	1B	1.01B	733.14M	601.15M	527.89M	422.87M	331.55M	248.14M
Income Tax Expense	1.6M	-1.82M	5.7M	1.04M	1.21M	3.28M	514K	-16.2M	35K
Shares Outstanding (Basic)	90.54M	73.54M	69.91M	67.8M	60.85M	56.58M	49.78M	42.45M	39.59M
Shares Outstanding (Diluted)	90.54M	73.54M	69.91M	67.8M	60.85M	56.58M	49.78M	42.45M	39.59M
EPS (Basic)	-6.29	-8.25	-10.12	-6.7	-3.07	-7.12	-3.97	-7.12	-6.21
EPS (Diluted)	-6.29	-8.25	-10.12	-6.7	-3.07	-7.12	-3.97	-7.12	-6.21
EBITDA	-469M	-516.45M	-640.51M	-410.32M	-139.81M	-389.77M	-177.56M	-312.51M	-244.58M
EBIT	-504.55M	-542.46M	-658.71M	-423.56M	-152.07M	-398.31M	-197.1M	-318.34M	-248.01M
Depreciation & Amortization	35.54M	26.01M	18.2M	13.24M	12.26M	8.54M	19.54M	5.83M	3.42M